Heterozygous familial hypercholesterolaemia in a pair of identical twins: A case report and updated review
Background: Familial hypercholesterolaemia (FH) is the most common inherited metabolic disease with an autosomal dominant mode of inheritance. It is characterised by raised serum levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c), leading to premature coronary artery di...
Published in: | BMC Pediatrics |
---|---|
Main Author: | Mohd Nor N.S.; Al-Khateeb A.M.; Chua Y.-A.; Mohd Kasim N.A.; Mohd Nawawi H. |
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd.
2019
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064193807&doi=10.1186%2fs12887-019-1474-y&partnerID=40&md5=d89580204d14cb2e064e9e8878d53c35 |
Similar Items
-
A case report of heterozygous familial hypercholesterolaemia with LDLR gene mutation complicated by premature coronary artery disease detected in primary care
by: Abdul-Halim M.A.Z.; Abdul-Hamid H.; Baharudin N.; Mohamed-Yassin M.-S.; Kasim S.S.; Nawawi H.; Qureshi N.; Ramli A.S.
Published: (2024) -
Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort
by: Nazli S.A.; Chua Y.-A.; Mohd Kasim N.A.; Ismail Z.; Md Radzi A.B.; Ibrahim K.S.; Kasim S.S.; Rosman A.; Nawawi H.
Published: (2022) -
Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: A case control study
by: Rahman T.; Hamzan N.S.; Mokhsin A.; Rahmat R.; Ibrahim Z.O.; Razali R.; Thevarajah M.; Nawawi H.
Published: (2017) -
Case-finding and genetic testing for familial hypercholesterolaemia in primary care
by: Qureshi N.; Akyea R.K.; Dutton B.; Humphries S.E.; Hamid H.A.; Condon L.; Weng S.F.; Kai J.; Roderick P.; Neely D.; Neil A.; Williams S.; Jones M.; Walters K.; Payne K.; Hanratty B.
Published: (2021) -
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
by: Vallejo-Vaz A.J.; Stevens C.A.T.; Lyons A.R.M.; Dharmayat K.I.; Freiberger T.; Hovingh G.K.; Mata P.; Raal F.J.; Santos R.D.; Soran H.; Watts G.F.; Abifadel M.; Aguilar-Salinas C.A.; Alhabib K.F.; Alkhnifsawi M.; Almahmeed W.; Alnouri F.; Alonso R.; Al-Rasadi K.; Al-Sarraf A.; Al-Sayed N.; Araujo F.; Ashavaid T.F.; Banach M.; Béliard S.; Benn M.; Binder C.J.; Bogsrud M.P.; Bourbon M.; Chlebus K.; Corral P.; Davletov K.; Descamps O.S.; Durst R.; Ezhov M.; Gaita D.; Genest J.; Groselj U.; Harada-Shiba M.; Holven K.B.; Kayikcioglu M.; Khovidhunkit W.; Lalic K.; Latkovskis G.; Laufs U.; Liberopoulos E.; Lima-Martinez M.M.; Lin J.; Maher V.; Marais A.D.; März W.; Mirrakhimov E.; Miserez A.R.; Mitchenko O.; Nawawi H.; Nordestgaard B.G.; Panayiotou A.G.; Paragh G.; Petrulioniene Z.; Pojskic B.; Postadzhiyan A.; Raslova K.; Reda A.; Reiner Ž.; Sadiq F.; Sadoh W.E.; Schunkert H.; Shek A.B.; Stoll M.; Stroes E.; Su T.-C.; Subramaniam T.; Susekov A.V.; Tilney M.; Tomlinson B.; Truong T.H.; Tselepis A.D.; Tybjærg-Hansen A.; Cárdenas A.V.; Viigimaa M.; Wang L.; Yamashita S.; Tokgozoglu L.; Catapano A.L.; Ray K.K.
Published: (2021)